Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression
Depression is one of the leading causes of disability worldwide. Common treatments like antidepressant medications and talk therapy work well for some people, …
Depression - Major Depressive DisorderTreatment-resistant Depression (TRD)rTMS+2 more
Estimated
~$10 – $6,250
Weill Medical College of Cornell UniversityNCT07680140
Phase 2
A Randomized, Double-blind, Placebo-controlled Trial of ALTO-207 in Adults With Treatment-resistant Depression
The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Treatment-resistant Depression (TRD)
Estimated
~$10 – $7,500
Alto NeuroscienceNCT07553637